Displaying 11 - 20 of 1788
Comment
02.25.2026
On February 25, 2026, Sophia Tripoli, senior director of health policy at Families USA, submitted written testimony to the Nebraska Committee on Health and Human Services, in support of Legislative Bill (LB) 777 –…
Comment
02.24.2026
Families USA submitted comment on the Centers for Medicare & Medicaid Services (CMS) model GUARD (Guarding U.S. Medicare Against Rising Drug Costs). Families USA supports the broader efforts to test new payment approaches to…
Insights Column
02.17.2026
The Trump Administration’s Latest Attack on Medically Necessary, Gender- Affirming Care The Trump administration is continuing its attacks on access to health care for transgender Americans, this time by cutting off Medicare and Medicaid…
Comment
02.17.2026
Families USA submitted comments on the Centers for Medicare & Medicaid Services (CMS) proposed rule Medicare and Medicaid Programs; Hospital Conditions of Participation: Limiting Participation Based on the Performance of Sex Trait Modification Procedures…
Insights Column
02.13.2026
President Trump and HHS Secretary Kennedy are reshaping America’s public health infrastructure by taking unprecedented steps to alter the childhood vaccine schedule — changes driven by ideology rather than scientific evidence. These actions have…
Comment
02.13.2026
On February 10th, 2026, Families USA submitted written testimony to the New York State Joint Legislative Budget Hearing on Health, expressing support for the Fair Pricing Act (S. 705/A. 2140). The Fair Pricing Act would ensure that…
Comment
02.11.2026
Families USA submitted a statement on the Energy and Commerce Health Subcommittee outlining how big drug companies and Pharmacy Benefit Managers (PBM) are driving up the cost of prescription drugs. Our statement recommends Congress…
Issue Brief
02.10.2026
The Medicare Advantage (MA) program — now covering more than 33 million older adults — was created to deliver higher-quality, more coordinated care at a lower cost. Yet unchecked corporate profiteering within the program…
Insights Column
02.09.2026
For decades, policymakers talked about lowering prescription drug prices — in 2022, Congress actually did something about it by passing the Inflation Reduction Act which gave Medicare, for the first time, the power to directly negotiate with drug…
Insights Column
01.30.2026
Recapping Health Action 2026, and spotlighting two Families USA storytellers who testified before Congress Families USA kicked off the year with more than 700 health care advocates in Washington, D.C. to strategize, educate, and…